Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology

被引:402
作者
Akwii, Racheal G. [1 ]
Sajib, Md S. [1 ]
Zahra, Fatema T. [1 ]
Mikelis, Constantinos M. [1 ]
机构
[1] Texas Tech Univ, Sch Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Amarillo, TX 79106 USA
基金
美国国家卫生研究院;
关键词
angiopoietin-2; Tie1; Tie2; integrin; angiogenesis; endothelial cells; cancer; inflammation; ENDOTHELIAL GROWTH-FACTOR; TIE-2 LIGAND ANGIOPOIETIN-2; RECEPTOR TYROSINE KINASE; FLOW-MEDIATED DILATION; GENE-EXPRESSION; MICROCIRCULATORY PERFUSION; PLASMA ANGIOPOIETIN-1; KAPOSIS-SARCOMA; CELL SURVIVAL; TUMOR-GROWTH;
D O I
10.3390/cells8050471
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Angiopoietins 1-4 (Ang1-4) represent an important family of growth factors, whose activities are mediated through the tyrosine kinase receptors, Tie1 and Tie2. The best characterized are angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2). Ang1 is a potent angiogenic growth factor signaling through Tie2, whereas Ang2 was initially identified as a vascular disruptive agent with antagonistic activity through the same receptor. Recent data demonstrates that Ang2 has context-dependent agonist activities. Ang2 plays important roles in physiological processes and the deregulation of its expression is characteristic of several diseases. In this review, we summarize the activity of Ang2 on blood and lymphatic endothelial cells, its significance in human physiology and disease, and provide a current view of the molecular signaling pathways regulated by Ang2 in endothelial cells.
引用
收藏
页数:19
相关论文
共 136 条
[1]   Angiopoietin-2 in white adipose tissue improves metabolic homeostasis through enhanced angiogenesis [J].
An, Yu A. ;
Sun, Kai ;
Joffin, Nolwenn ;
Zhang, Fang ;
Deng, Yingfeng ;
Donze, Olivier ;
Kusminski, Christine M. ;
Scherer, Philipp E. .
ELIFE, 2017, 6
[2]   Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis [J].
Belloni, Daniela ;
Marcatti, Magda ;
Ponzoni, Maurilio ;
Ciceri, Fabio ;
Veschini, Lorenzo ;
Corti, Angelo ;
Cappio, Federico Caligaris ;
Ferrarini, Marina ;
Ferrero, Elisabetta .
EXPERIMENTAL CELL RESEARCH, 2015, 330 (01) :1-12
[3]   Clinical correlates and heritability of flow-mediated dilation in the community - The Framingham Heart Study [J].
Benjamin, EJ ;
Larson, MG ;
Keyes, MJ ;
Mitchell, GF ;
Vasan, RS ;
Keaney, JF ;
Lehman, BT ;
Fan, SX ;
Osypiuk, E ;
Vita, JA .
CIRCULATION, 2004, 109 (05) :613-619
[4]   Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden [J].
Bohn, Kaci A. ;
Adkins, Chris E. ;
Nounou, Mohamed I. ;
Lockman, Paul R. .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[5]   Vasculotide, an Angiopoietin-1 mimetic, ameliorates several features of experimental atopic dermatitis-like disease [J].
Bourdeau A. ;
Van Slyke P. ;
Kim H. ;
Cruz M. ;
Smith T. ;
Dumont D.J. .
BMC Research Notes, 9 (1)
[6]   Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma [J].
Brown, LF ;
Dezube, BJ ;
Tognazzi, K ;
Dvorak, HF ;
Yancopoulos, GD .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (06) :2179-2183
[7]   The angiopoietin/tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy [J].
Cai, Jun ;
Kehoe, Oksana ;
Smith, Gill M. ;
Hykin, Philip ;
Boulton, Michael E. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (05) :2163-2171
[8]   Direct cell adhesion to the angiopoietins mediated by integrins [J].
Carlson, TR ;
Feng, YZ ;
Maisonpierre, PC ;
Mrksich, M ;
Morla, AO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26516-26525
[9]   Angiopoietin-2 (Ang-2) is a useful serum tumor marker for liver cancer in the Chinese population [J].
Chen, Yuxin ;
Wu, Yanping ;
Zhang, Xiao ;
Zeng, Hong ;
Liu, Ya ;
Wu, Qi ;
Chen, Yan ;
Zhu, GuoQing ;
Pan, Qiuhui ;
Jin, Lei ;
Guo, Lin ;
Sun, Fenyong .
CLINICA CHIMICA ACTA, 2018, 478 :18-27
[10]   Targeting pericytes for therapeutic approaches to neurological disorders [J].
Cheng, Jinping ;
Korte, Nils ;
Nortley, Ross ;
Sethi, Huma ;
Tang, Yamei ;
Attwell, David .
ACTA NEUROPATHOLOGICA, 2018, 136 (04) :507-523